Feb. 13, 2012
/PRNewswire/ - Patheon Inc. (TSX: PTI), a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today that
has resigned as Chairman of the Board and a Director of Patheon Inc. effective today. The Board has appointed
Paul S. Levy
, Managing Director, JLL Partners, as Patheon's new Chairman. Mr. Levy joined the Board in
Mr. Levy founded JLL Partners in 1988. Prior to founding JLL Partners, Mr. Levy was a Managing Director at Drexel Burnham Lambert. Previously, Mr. Levy was Chief Executive Officer of Yves Saint Laurent Inc., Vice President of Administration and General Counsel of Quality Care, Inc., and an attorney at Stroock & Stroock & Lavan LLP.
Patheon is also pleased to announce the appointment of
, Associate, JLL Partners, to its Board of Directors, filling the vacant seat left by the departure of Mr. Frank. Mr. O'Leary joined JLL Partners in 2009. Prior to that, Mr. O'Leary worked as an analyst with Merrill Lynch & Co., Mergers and Acquisitions Group. He received a B.A, Economics from
Washington and Lee University
magna cum laude
and Phi Beta Kappa.
As well, Mr.
has been appointed Chair of Patheon's Corporate Governance Committee. Mr. Lagarde joined JLL Partners in 2008 and Patheon's Board of Directors in
. He was previously the CEO and CFO of the Domestic Appliances and Personal Care division of Philips Electronics North America. He also held positions as CFO of Philips Electronics Indonesia and Financial Controller of Philips Electronics Hong Kong. Mr. Lagarde currently serves on the Boards of ACE Cash Express and SOS Children's Villages -
. He received a B.B.A from
European University Antwerp
and an Executive Master in Finance and Control from the University of
, Managing Director at JLL Partners, Inc., and a current member of the Board, will become a member of Patheon's Corporate Governance Committee, filling the position vacated by Mr. Clark. Mr. Agroskin joined JLL Partners in 2005. Prior to joining JLL, he worked at JP Morgan Partners and in Merrill Lynch's Mergers and Acquisitions Group. Mr. Agroskin is a graduate of
and the Wharton School of the
University of Pennsylvania
. He joined Patheon's Board of Directors in
Patheon Inc. (TSX: PTI) is a leading global provider of contract development and manufacturing services to the global pharmaceutical industry. The company provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. Its services range from preclinical development through commercial manufacturing of a full array of dosage forms including parenteral, solid and liquid forms.